(17314506), R. L., (17314509), E. M., (17314512), A. L., (17314515), N. G., (17314518), I. C., (17314521), A. A., . . . (17314731), D. V. (2025). Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Chicago-viite (17. p.)(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.
MLA-viite (9. p.)(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.